Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nils Rettby"'
Autor:
Shinichi Makita, Go Yamamoto, Dai Maruyama, Yuki Asano‐Mori, Daisuke Kaji, Revathi Ananthakrishnan, Ken Ogasawara, Lara Stepan, Claudia Schusterbauer, Nils Rettby, Jens Hasskarl, Koji Izutsu
Publikováno v:
Cancer Medicine, Vol 11, Iss 24, Pp 4889-4899 (2022)
Abstract The autologous anti‐CD19 chimeric antigen receptor (CAR) T‐cell product, lisocabtagene maraleucel (liso‐cel), is administered at equal target doses of CD8+ and CD4+ CAR+ T cells. This analysis assessed safety and efficacy of liso‐cel
Externí odkaz:
https://doaj.org/article/01555f722268410baca0cc3cbf1c71db
Autor:
Carla Casulo, Armando Santoro, Guillaume Cartron, Kiyoshi Ando, Javier Munoz, Steven Le Gouill, Koji Izutsu, Simon Rule, Pieternella Lugtenburg, Jia Ruan, Luca Arcaini, Marie‐Laure Casadebaig, Brian Fox, Nurgul Kilavuz, Nils Rettby, Justine Dell'Aringa, Lilia Taningco, Richard Delarue, Myron Czuczman, Thomas Witzig
Publikováno v:
Cancer Reports, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Background Studies suggest that immune checkpoint inhibitors may represent a promising strategy for boosting immune responses and improving the antitumor activity of standard therapies in patients with relapsed/refractory hematologic maligna
Externí odkaz:
https://doaj.org/article/53982eb6c7094c0dbc546b6a65f550a0
Autor:
Nils Rettby, Oriol Manuel, Giuseppe Pantaleo, Matthieu Perreau, Matteo Mombelli, Manuel Pascual
Publikováno v:
Vaccine. 36:6163-6169
Background The use of vaccines with higher doses of antigen is an attractive strategy to improve the immunogenicity of influenza vaccination in transplant recipients. However, the effect of vaccination with a double-dose (DD) containing 30 µg of ant
Autor:
Julie Liberman, Pierre-Alexandre Bart, Laurent-Dominique Piveteau, Paul Vescovo, Reto Zanoni, Nirinarilala Ramaniraka, Astrid Cachemaille, Giuseppe Pantaleo, Nils Rettby, Karen Hart
Publikováno v:
Vescovo, Paul; Rettby, Nils; Ramaniraka, Nirinarilala; Liberman, Julie; Hart, Karen; Cachemaille, Astrid; Piveteau, Laurent-Dominique; Zanoni, Reto Giacomo; Bart, Pierre-Alexandre; Pantaleo, Giuseppe (2017). Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™. Vaccine, 35(14), pp. 1782-1788. Elsevier 10.1016/j.vaccine.2016.09.069
Vaccine, vol. 35, no. 14, pp. 1782-1788
Vaccine, vol. 35, no. 14, pp. 1782-1788
In a single-center study, 66 healthy volunteers aged between 18 and 50years were randomized to be immunized against rabies with three different injection routes: intradermal with DebioJect™ (IDJ), standard intradermal with classical needle (IDS), a
Autor:
G. Laissa Ouedraogo, Holly Janes, Nils Rettby, Song Ding, Peter B. Gilbert, Pierre-Alexandre Bart, M. Juliana McElrath, Shelly Karuna, Carter Lee, Lawrence Corey, Shannon Grant, Giuseppe Pantaleo, Merlin L. Robb, Guido Ferrari, Nicole Frahm, Mariano Esteban, Mary Allen, David C. Montefiori, Ralf Wagner, James G. Kublin, Georgia D. Tomaras
Publikováno v:
The Lancet. HIV
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
instname
©2019 The Author(s).
[Background]: Up to now, immunisation regimens that have been assessed for development of HIV vaccines have included purified envelope (Env) protein among the boosting components of the regimen. We postulated that co-admini
[Background]: Up to now, immunisation regimens that have been assessed for development of HIV vaccines have included purified envelope (Env) protein among the boosting components of the regimen. We postulated that co-admini
Autor:
Giuseppe Pantaleo, Holly Janes, Shelly Karuna, Shannon Grant, Laissa Ouedraogo, Mary Allen, Georgia D. Tomaras, Nicole Frahm, David C. Montefiori, Guido Ferrari, Song Ding, Carter Lee, Merlin L. Robb, Mariano Esteban, Ralf Wagner, Pierre Alexandre-Bart, Nils Rettby, M. Juliana McElrath, Peter B. Gilbert, James Kublin, Lawrence Corey, NIAID HIV Vaccine Trials Network
Publikováno v:
SSRN Electronic Journal.
Background: The immunization regimens evaluated to date in the development of HIV vaccines have included purified Env protein vaccines as a part of the boosting components of the vaccination regimen. In the present study, we tested the hypothesis tha
Autor:
François Spertini, Nils Rettby, Viviane Steiner-Monard, Juana Doce, Nacho Aguilo, Reza Chakour, Eugenia Puentes, Carlos Martin, Régine Audran, Laure Vallotton, Catherine Lazor-Blanchet, Dessislava Marinova, Carole Mayor, Anne-Christine Thierry, Olfa Karoui, Katia Jaton
Publikováno v:
Lancet. Respiratory Medicine, vol. 3, no. 12, pp. 953-962
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Summary Background Tuberculosis remains one of the world's deadliest transmissible diseases despite widespread use of the BCG vaccine. MTBVAC is a new live tuberculosis vaccine based on genetically attenuated Mycobacterium tuberculosis that expresses
Autor:
Steven Le Gouill, Richard Delarue, John Radford, Carla Casulo, Antonello Pinto, Brian Fox, Koji Izutsu, Javier Munoz, Luca Arcaini, Marie-Laure Casadebaig, Guillaume Cartron, Kiyoshi Ando, Jia Ruan, Justine Dell’Aringa, Kathryn Newhall, Myron S. Czuczman, Simon Rule, Nils Rettby, Reda Bouabdallah, Armando Santoro
Publikováno v:
Blood. 134:5320-5320
Introduction: Targeting immune cells in the tumor microenvironment is an attractive approach to improving antitumor activity of standard therapy in r/r hematologic malignancies. Durvalumab is a monoclonal antibody that blocks programmed cell death li
Autor:
Nils Rettby, Antonio Pinto, Simon Rule, Nathan Fowler, Thomas E. Witzig, Myron S. Czuczman, Kiyoshi Ando, Carla Casulo, Jia Ruan, Armando Santoro, Sabine De Bedout, Nurgul Kilavuz, Cathy Burton, Pier Luigi Zinzani, Guillaume Cartron, Steven Le Gouill
Publikováno v:
Journal of Clinical Oncology. 35:TPS7574-TPS7574
TPS7574 Background: The PD-1/PD-L1 pathway is an important immune checkpoint used by tumor cells to evade immune cell detection and inhibit antitumor responses. PD-1/PD-L1 expression in multiple hematologic malignancies may provide an effective targe